Corrigendum: Neurological adverse events associated with esketamine: A disproportionality analysis for signal detection leveraging the FDA adverse event reporting system

Detalles Bibliográficos
Autores principales: Guo, Haoning, Wang, Bin, Yuan, Shuying, Wu, Silin, Liu, Jing, He, Miaoquan, Wang, Jisheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9683689/
https://www.ncbi.nlm.nih.gov/pubmed/36438806
http://dx.doi.org/10.3389/fphar.2022.1075966
_version_ 1784835108376674304
author Guo, Haoning
Wang, Bin
Yuan, Shuying
Wu, Silin
Liu, Jing
He, Miaoquan
Wang, Jisheng
author_facet Guo, Haoning
Wang, Bin
Yuan, Shuying
Wu, Silin
Liu, Jing
He, Miaoquan
Wang, Jisheng
author_sort Guo, Haoning
collection PubMed
description
format Online
Article
Text
id pubmed-9683689
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-96836892022-11-24 Corrigendum: Neurological adverse events associated with esketamine: A disproportionality analysis for signal detection leveraging the FDA adverse event reporting system Guo, Haoning Wang, Bin Yuan, Shuying Wu, Silin Liu, Jing He, Miaoquan Wang, Jisheng Front Pharmacol Pharmacology Frontiers Media S.A. 2022-11-09 /pmc/articles/PMC9683689/ /pubmed/36438806 http://dx.doi.org/10.3389/fphar.2022.1075966 Text en Copyright © 2022 Guo, Wang, Yuan, Wu, Liu, He and Wang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Guo, Haoning
Wang, Bin
Yuan, Shuying
Wu, Silin
Liu, Jing
He, Miaoquan
Wang, Jisheng
Corrigendum: Neurological adverse events associated with esketamine: A disproportionality analysis for signal detection leveraging the FDA adverse event reporting system
title Corrigendum: Neurological adverse events associated with esketamine: A disproportionality analysis for signal detection leveraging the FDA adverse event reporting system
title_full Corrigendum: Neurological adverse events associated with esketamine: A disproportionality analysis for signal detection leveraging the FDA adverse event reporting system
title_fullStr Corrigendum: Neurological adverse events associated with esketamine: A disproportionality analysis for signal detection leveraging the FDA adverse event reporting system
title_full_unstemmed Corrigendum: Neurological adverse events associated with esketamine: A disproportionality analysis for signal detection leveraging the FDA adverse event reporting system
title_short Corrigendum: Neurological adverse events associated with esketamine: A disproportionality analysis for signal detection leveraging the FDA adverse event reporting system
title_sort corrigendum: neurological adverse events associated with esketamine: a disproportionality analysis for signal detection leveraging the fda adverse event reporting system
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9683689/
https://www.ncbi.nlm.nih.gov/pubmed/36438806
http://dx.doi.org/10.3389/fphar.2022.1075966
work_keys_str_mv AT guohaoning corrigendumneurologicaladverseeventsassociatedwithesketamineadisproportionalityanalysisforsignaldetectionleveragingthefdaadverseeventreportingsystem
AT wangbin corrigendumneurologicaladverseeventsassociatedwithesketamineadisproportionalityanalysisforsignaldetectionleveragingthefdaadverseeventreportingsystem
AT yuanshuying corrigendumneurologicaladverseeventsassociatedwithesketamineadisproportionalityanalysisforsignaldetectionleveragingthefdaadverseeventreportingsystem
AT wusilin corrigendumneurologicaladverseeventsassociatedwithesketamineadisproportionalityanalysisforsignaldetectionleveragingthefdaadverseeventreportingsystem
AT liujing corrigendumneurologicaladverseeventsassociatedwithesketamineadisproportionalityanalysisforsignaldetectionleveragingthefdaadverseeventreportingsystem
AT hemiaoquan corrigendumneurologicaladverseeventsassociatedwithesketamineadisproportionalityanalysisforsignaldetectionleveragingthefdaadverseeventreportingsystem
AT wangjisheng corrigendumneurologicaladverseeventsassociatedwithesketamineadisproportionalityanalysisforsignaldetectionleveragingthefdaadverseeventreportingsystem

Ejemplares similares